| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &Group Pres, Cardiology | EVP &Pres, Cardiology | EVP &Pres, Interven Cardio +1 more
1 company
Fitzgerald Joseph Michael serves as an EVP &Group Pres, Cardiology at BSX. Across recent SEC filings that breaks down to 1 buy and 20 sells. Those positions are worth an estimated $3.0M at current prices.
Historically, Fitzgerald Joseph Michael's trades have earned a middling insider score of 54/100 across 16 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -12.1%.
The biggest single holding is BSX (~$3.0M) as EVP &Group Pres, Cardiology. The recent filings there lean toward selling, a net 888,201 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2025 | BSX Boston Scientific Corp | EVP &Group Pres, Cardiology | Sale+OE | 50,000 | $99.47 | $4,973,337.63 | -21.9% | -6.8% | - | |
| Oct 1, 2025 | BSX Boston Scientific Corp | EVP &Group Pres, Cardiology | Sale+OE | 50,000 | $98.47 | $4,923,326.82 | -21.9% | +0.2% | -54.9% | |
| Sep 2, 2025 | BSX Boston Scientific Corp | EVP &Group Pres, Cardiology | Sale+OE | 50,000 | $105.43 | $5,271,416.44 | -21.9% | -5.3% | -54.7% | |
| Aug 1, 2025 | BSX Boston Scientific Corp | EVP &Group Pres, Cardiology | Sale+OE | 50,000 | $104.63 | $5,231,670.00 | -21.9% | -4.6% | -55.7% | |
| Jul 1, 2025 | BSX Boston Scientific Corp | EVP &Group Pres, Cardiology | Sale+OE | 50,000 | $106.97 | $5,348,315.00 | -21.9% | -7.4% | -58.9% | |
| Jun 4, 2025 | BSX Boston Scientific Corp | EVP &Group Pres, Cardiology | Sale+OE | 56,372 | $102.88 | $5,799,630.28 | -24.0% | +4.1% | -52.3% | |
| Dec 10, 2024 | BSX Boston Scientific Corp | EVP &Group Pres, Cardiology | Sell | 20 | $89.97 | $1,799.44 | - | +4.4% | +2.8% | |
| Dec 3, 2024 | BSX Boston Scientific Corp | EVP &Group Pres, Cardiology | Buy | 50 | $90.29 | $4,514.60 | - | +15.9% | +9.0% | |
| Oct 7, 2024 | BSX Boston Scientific Corp | EVP &Group Pres, Cardiology | Sale+OE | 132,527 | $85.00 | $11,264,887.77 | -45.2% | +8.2% | +13.6% | |
| Aug 28, 2024 | BSX Boston Scientific Corp | EVP &Group Pres, Cardiology | Sell | 14,132 | $80.00 | $1,130,560.00 | -7.4% | +13.4% | +33.0% |